Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.16−0.01 (-7.03%)
Close on Nov 12, 2026Market cap $120.89KP/E –Yield –
Endovia Health Sciences operating margin
Operating margin is operating income as a percentage of revenue.
Endovia Health Sciences's operating margin for the twelve months ending Sep 30, 2025 was -916.9%. For fiscal 2025 it was -19415.6%, against -1235.6% the year before. The highest annual figure on record is 5.1% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -19415.6% | −18180.0 |
| FY2024 | Dec 31, 2024 | -1235.6% | −1154.5 |
| FY2023 | Dec 31, 2023 | -81.1% | +37.2 |
| FY2022 | Dec 31, 2022 | -118.3% | +138.7 |
| FY2021 | Dec 31, 2021 | -257.0% | +510.9 |
| FY2020 | Dec 31, 2020 | -767.9% | +21241.6 |
| FY2019 | Dec 31, 2019 | -22009.4% | −22014.5 |
| FY2018 | Dec 31, 2018 | 5.1% | +22.7 |
| FY2017 | Dec 31, 2017 | -17.6% | −12.6 |
| FY2016 | Dec 31, 2016 | -4.9% | −7.0 |
| FY2015 | Dec 31, 2015 | 2.1% | +6.7 |
| FY2014 | Dec 31, 2014 | -4.6% | −4.7 |
| FY2013 | Dec 31, 2013 | 0.1% | +3.1 |
| FY2012 | Dec 31, 2012 | -3.0% | +14.5 |
| FY2011 | Dec 31, 2011 | -17.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -23176.4% | −23126.9 |
| Q3 FY2025 | Sep 30, 2025 | -2428.2% | −2156.3 |
| Q2 FY2025 | Jun 30, 2025 | -406.3% | −53.7 |
| Q1 FY2025 | Mar 31, 2025 | -2417.1% | −2206.2 |
| Q4 FY2024 | Dec 31, 2024 | -49.4% | +72.8 |
| Q3 FY2024 | Sep 30, 2024 | -271.9% | −187.8 |
| Q2 FY2024 | Jun 30, 2024 | -352.6% | −253.0 |
| Q1 FY2024 | Mar 31, 2024 | -211.0% | −106.0 |
| Q4 FY2023 | Dec 31, 2023 | -122.3% | +7.3 |
| Q3 FY2023 | Sep 30, 2023 | -84.0% | +60.7 |
| Q4 FY2022 | Dec 31, 2022 | -99.6% | +101.4 |
| Q3 FY2022 | Sep 30, 2022 | -104.9% | +322.0 |
| Q2 FY2022 | Jun 30, 2022 | -129.6% | +74.5 |
| Q1 FY2022 | Mar 31, 2022 | -144.8% | +67.9 |
| Q4 FY2021 | Dec 31, 2021 | -200.9% | +1033.4 |
| Q3 FY2021 | Sep 30, 2021 | -427.0% | −114.8 |
| Q2 FY2021 | Jun 30, 2021 | -204.0% | −103.4 |
| Q1 FY2021 | Mar 31, 2021 | -212.7% | +1170.5 |
| Q4 FY2020 | Dec 31, 2020 | -1234.4% | −985.0 |
| Q3 FY2020 | Sep 30, 2020 | -312.2% | −29.9 |
| Q2 FY2020 | Jun 30, 2020 | -100.7% | +619.7 |
| Q1 FY2020 | Mar 31, 2020 | -1383.1% | +15445.4 |
| Q4 FY2019 | Dec 31, 2019 | -249.4% | −244.1 |
| Q3 FY2019 | Sep 30, 2019 | -282.3% | −281.6 |
| Q2 FY2019 | Jun 30, 2019 | -720.4% | −739.7 |
| Q1 FY2019 | Mar 31, 2019 | -16828.5% | −16833.1 |
| Q4 FY2018 | Dec 31, 2018 | -5.2% | +63.8 |
| Q3 FY2018 | Sep 30, 2018 | -0.7% | −11.1 |
| Q2 FY2018 | Jun 30, 2018 | 19.3% | +29.6 |
| Q1 FY2018 | Mar 31, 2018 | 4.6% | +33.8 |
| Q4 FY2017 | Dec 31, 2017 | -69.0% | −63.9 |
| Q3 FY2017 | Sep 30, 2017 | 10.4% | +15.5 |
| Q2 FY2017 | Jun 30, 2017 | -10.3% | −5.1 |
| Q1 FY2017 | Mar 31, 2017 | -29.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -5.1% | – |
| Q3 FY2016 | Sep 30, 2016 | -5.2% | – |
| Q2 FY2016 | Jun 30, 2016 | -5.2% | – |
See a number that looks wrong?